NEW AND EMERGING THERAPIES FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy Saturday, October 20, 2012 8:30 a.m.–4:30 p.m.

ACCP 2012 Annual Meeting * October 21-24, 2012 * Hollywood, Florida

About From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy
From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP).

This live education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

More information on the BCACP recertification professional development program is available at www.accp.com/careers/boardbcacp.aspx.

Activity Overview
“New and Emerging Therapies for the Management of Type 2 Diabetes Mellitus” will provide an overview of new and emerging therapies for the management of patients with type 2 diabetes mellitus and discuss strategies that help inform individual patient care and formulary decisions. Sessions will address management guidelines, medication safety, formulary and pharmacoeconomic considerations, and pharmacist services.

Target Audience
Clinical pharmacists caring for patients with type 2 diabetes mellitus and BCACPs seeking recertification credit by continuing education

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-12-088-L01-P.

To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must attend all 6.0 contact hours of programming and complete the associated evaluation at www.accp.com/ce. Partial credit is not available for this activity.

BCACP Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCACPs must attend all 6.0 contact hours of live programming and successfully complete a Web-based posttest by November 30, 2012. Partial credit is not available for this activity.

Activity Goals

1. Provide an overview of new and emerging antidiabetic agents.
2. Discuss the role of new agents and management strategies to optimize cost-effective patient care and minimize adverse drug events.
3. Identify quality metrics for pharmacist services providing care to patients with type 2 diabetes mellitus.

Agenda

8:30 a.m.	Introduction
8:45 a.m.	The Science of Diabetes Medications: Therapeutic Implications
9:45 a.m.	Break
10:00 a.m.	New and Emerging Antidiabetic Agents—Scientific and Clinical Evidence
11:00 a.m.	Management Guidelines—Integrating New Therapeutic Strategies
12:00 p.m.	Lunch
1:30 p.m.	Diabetes Medication Safety: Clinical Considerations and Impact on Health Care
2:30 p.m.	Formulary and Pharmacoeconomic Considerations
3:00 p.m.	Break
3:15 p.m.	Pharmacist Services—Patient Outcomes and Best Practices
4:15 p.m.	Closing Remarks

Learning objectives for each of the sessions are available at www.accp.com/meetings/am12/.

Program Faculty

	Amie D. McCord Brooks, Pharm.D., BCPS Associate Professor Division of Pharmacy Practice Saint Louis College of Pharmacy Clinical Pharmacist in Primary Care Saint Louis County Department of Health St. Louis, Missouri
	Krystal L. Edwards, Pharm.D., BCPS Associate Professor Texas Tech School of Pharmacy Dallas, Texas
	Laura Shane-McWhorter, PharmD., BCPS, BC-ADM, CDE, FASCP, FAADE Professor (Clinical) Department of Pharmacotherapy University of Utah College of Pharmacy Salt Lake City, Utah

Program Reviewers
Julie Bartell, Pharm.D., BCACP, CACP
Pharmacotherapist, Residency Director
Monroe Clinic
Monroe, Wisconsin

Brian K. Irons, Pharm.D., FCCP, BCACP, BCPS, BC-ADM
Associate Professor of Pharmacy Practice
Division Head-Ambulatory Care
Texas Tech University Health Sciences Center
Lubbock, Texas

Michael P. Kane, Pharm.D., FCCP, BCPS, BCACP
Professor
Albany College of Pharmacy and Health Sciences
Albany, New York

Registration Fee

Registration fee includes syllabus, CPE credit, and access to the BCACP recertification posttest.

Full information on the agenda, learning objectives, faculty, and registration is available at www.accp.com/meetings/am12/.

No commercial support has been received for this activity.